Paper19200421
Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial.
van der Loos ML and 11 others. J Clin Psychiatry, 2009. Cited by 160 papers, by iCite.
Cite this record
ConductScience Library. Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial. Papers, record 19200421. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19200421
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anticonvulsants | Major topic |
| Antimanic Agents | Major topic |
| Bipolar Disorder | Major topic |
| Major Depressive Disorder | Major topic |
| Lithium Carbonate | Major topic |
| Triazines | Major topic |
| Adult | |
| Dose-Response Relationship, Drug | |
| Double-Blind Method | |
| Drug Administration Schedule | |
| Drug Therapy, Combination | |
| Female | |
| Humans | |
| Lamotrigine | |
| Male | |
| Middle Aged | |
| Psychiatric Status Rating Scales |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT00224510 | A Study To Investigate The Antidepressant Effect Of Lamotrigine In Patients With Bipolar Disorder Using Lithium | Background | Yes |
Source ClinicalTrials.gov
Cited by60
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 160 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42103384 | Lithium versus lamotrigine in bipolar disorder type II: protocol for a single-blinded, pragmatic, randomised controlled trial (the LiLa-Bipolar RCT). | BMJ Open | 2026 | https://conductscience.org/library/papers/42103384 | PubMed |
| 41977285 | The Regulatory Potential of Long Non-Coding RNAs in Bipolar Disorder. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41977285 | PubMed |
| 41155702 | Efficacy of Lamotrigine in the Treatment of Unipolar and Bipolar Depression: Meta-Analysis of Acute and Maintenance Randomised Controlled Trials. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41155702 | PubMed |
| 40371769 | Bipolar II disorder: a state-of-the-art review. | World Psychiatry | 2025 | https://conductscience.org/library/papers/40371769 | PubMed |
| 39015883 | Treatment of bipolar depression: clinical practice vs. adherence to guidelines-data from a Bavarian drug surveillance project. | Front Psychiatry | 2024 | https://conductscience.org/library/papers/39015883 | PubMed |
| 38694998 | Bipolar II Disorder: Understudied and Underdiagnosed. | Focus (Am Psychiatr Publ) | 2023 | https://conductscience.org/library/papers/38694998 | PubMed |
| 38592374 | Possible Role of Correlation Coefficients and Network Analysis of Multiple Intracellular Proteins in Blood Cells of Patients with Bipolar Disorder in Studying the Mechanism of Lithium Responsiveness: A Proof-Concept Study. | J Clin Med | 2024 | https://conductscience.org/library/papers/38592374 | PubMed |
| 37145986 | Pharmacological Treatment of Bipolar Depression: A Review of Observational Studies. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/37145986 | PubMed |
| 36676744 | Divergent Directionality of Immune Cell-Specific Protein Expression between Bipolar Lithium Responders and Non-Responders Revealed by Enhanced Flow Cytometry. | Medicina (Kaunas) | 2023 | https://conductscience.org/library/papers/36676744 | PubMed |
| 36561896 | Treatment-Resistant Bipolar Depression: Therapeutic Trends, Challenges and Future Directions. | Neuropsychiatr Dis Treat | 2022 | https://conductscience.org/library/papers/36561896 | PubMed |
| 36269465 | Efficacy and safety of adjunctive therapy to lamotrigine, lithium, or valproate monotherapy in bipolar depression: a systematic review and meta-analysis of randomized controlled trials. | Int J Bipolar Disord | 2022 | https://conductscience.org/library/papers/36269465 | PubMed |
| 35126052 | Glycogen Synthase Kinase-3 Inhibitors: Preclinical and Clinical Focus on CNS-A Decade Onward. | Front Mol Neurosci | 2021 | https://conductscience.org/library/papers/35126052 | PubMed |
| 34658633 | Acute and Maintenance Treatment of Bipolar Depression. | Noro Psikiyatr Ars | 2021 | https://conductscience.org/library/papers/34658633 | PubMed |
| 34646439 | Efficacy and safety of lamotrigine in the treatment of bipolar disorder across the lifespan: a systematic review. | Ther Adv Psychopharmacol | 2021 | https://conductscience.org/library/papers/34646439 | PubMed |
| 34523118 | Lamotrigine in the maintenance treatment of bipolar disorder. | Cochrane Database Syst Rev | 2021 | https://conductscience.org/library/papers/34523118 | PubMed |
| 34124858 | Lamotrigine for acute bipolar depression: An exploratory item-level analysis. | Brain Behav | 2021 | https://conductscience.org/library/papers/34124858 | PubMed |
| 32606699 | Pharmacological Treatment of Bipolar Depression: What are the Current and Emerging Options? | Neuropsychiatr Dis Treat | 2020 | https://conductscience.org/library/papers/32606699 | PubMed |
| 32553395 | Toward prevention of bipolar disorder in at-risk children: Potential strategies ahead of the data. | J Affect Disord | 2020 | https://conductscience.org/library/papers/32553395 | PubMed |
| 32047371 | Working With a Patient With Bipolar I Disorder Who Is Experiencing Depression. | Focus (Am Psychiatr Publ) | 2019 | https://conductscience.org/library/papers/32047371 | PubMed |
| 32047367 | Complex Combination Pharmacotherapy for Bipolar Disorder: Knowing When Less Is More or More Is Better. | Focus (Am Psychiatr Publ) | 2019 | https://conductscience.org/library/papers/32047367 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19200421
GET https://conductscience.org/api/papers/v1/19200421/cited_by?page=2